Compare BNR & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNR | BDL |
|---|---|---|
| Founded | 2014 | 1959 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.5M | 83.3M |
| IPO Year | 2019 | 1995 |
| Metric | BNR | BDL |
|---|---|---|
| Price | $9.36 | $45.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 20.8K | 5.4K |
| Earning Date | 06-05-2026 | 05-18-2026 |
| Dividend Yield | N/A | ★ 1.90% |
| EPS Growth | N/A | ★ 49.72 |
| EPS | N/A | ★ 1.98 |
| Revenue | N/A | ★ $205,248,000.00 |
| Revenue This Year | $111.65 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.07 |
| Revenue Growth | N/A | ★ 8.99 |
| 52 Week Low | $3.51 | $26.33 |
| 52 Week High | $41.72 | $47.99 |
| Indicator | BNR | BDL |
|---|---|---|
| Relative Strength Index (RSI) | 51.80 | 61.45 |
| Support Level | $8.05 | $29.14 |
| Resistance Level | $13.89 | $47.99 |
| Average True Range (ATR) | 0.85 | 2.37 |
| MACD | 0.55 | -0.07 |
| Stochastic Oscillator | 90.32 | 62.15 |
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.